TABLE 2.
Microfluidic applications for microbial and mammalian cells based on culture modes
Culture modes | Application | Cell types | Remarks |
---|---|---|---|
Batch | Screening for desired phenotypes | Escherichia coli | [138] |
Saccharomyces cerevisiae | [138] | ||
Pichia pastoris | [43] | ||
Yarrowia lipolytica | [42] | ||
Yeast | [32] | ||
Aspergillus niger | [33] | ||
Hybridoma cells | [44, 132] | ||
Antimicrobial susceptibility testing (AST) | Escherichia coli | [39, 40] | |
Klebsiella pneumoniae | [40] | ||
Staphylococcus aureus | [40, 139] | ||
Enterococcus faecalis | [40] | ||
Cell migration | Human breast cancer cell lines, human neutrophils | [140] | |
Cell‐cell interaction | Clonostachys rosea, Fusarium graminearum | [141] | |
Determination of monod kinetic parameter | Saccharomyces cerevisiae | [24, 142] | |
Fed‐Batch | Multidrug screening | A549 cells | [143] |
Optimise feeding strategies | Corynebacterium glutamicum | [18] | |
Perfusion | Bioprocess development | Pichia pastoris | [27] |
Saccharomyces cerevisiae | [21] | ||
CHO cell line | [97, 144] | ||
C2C12, HFF cell lines and mouse embryonic stem cells | [145] | ||
Cell migration | Pseudomonas putida | [146] | |
Human oral squamous cancer cell line, Human glioblastoma cell line | [147] | ||
Jurkat cell | [148] | ||
Cytotoxicity assay | HUVEC cells | [61] | |
Subculture | Adaptive evolution | Escherichia coli | [34, 126] |
3D culture | Cytotoxicity assay | HeLa cells | [149] |
Colon cancer cells (HCT116) | [81] | ||
Cell‐cell interaction | Tumour‐endothelial cell | [118] |